|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
258,990,000 |
Market
Cap: |
19.43(B) |
Last
Volume: |
1,451,370 |
Avg
Vol: |
1,905,632 |
52
Week Range: |
$65.11 - $82.04 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NASDAQ COMPOSITE |
|
S&P SMALLCAP 600 |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 317 |
Guru Rank Value : 4 |
Guru Occurances : 2 |
|
|
|
|
|
|
|
Company Profile Hologic develops, manufactures and supplies diagnostics products, medical imaging systems, and surgical products focused on women's health and well-being. Co.'s segments are: Diagnostics, which provides diagnostic products used in screening and diagnosis of human diseases; Breast Health, which provides solutions for breast cancer care in the areas of radiology, breast surgery, pathology and treatment; GYN Surgical, which include NovaSure endometrial ablation system, MyoSure hysteroscopic tissue removal system, Fluent fluid management system, as well as Acessa ProVu laparoscopic radiofrequency ablation system; and Skeletal Health, which include the Horizon DXA, a dual energy x-ray system.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
26,945 |
123,113 |
123,113 |
368,767 |
Total Sell Value |
$2,043,551 |
$8,902,469 |
$8,902,469 |
$27,563,219 |
Total People Sold |
3 |
6 |
6 |
10 |
Total Sell Transactions |
3 |
8 |
8 |
16 |
End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Oberton Karleen Marie |
Chief Financial Officer |
|
2020-11-02 |
4 |
A |
$0.00 |
$0 |
D/D |
16,941 |
51,358 |
|
- |
|
Verstreken Jan |
Group President, International |
|
2020-11-02 |
4 |
A |
$0.00 |
$0 |
D/D |
16,797 |
42,778 |
|
- |
|
Thornal Kevin R |
Div. President, Diagnostics |
|
2020-11-02 |
4 |
A |
$0.00 |
$0 |
D/D |
17,750 |
34,776 |
|
- |
|
Bebo Allison P |
SVP, Human Resources |
|
2020-11-02 |
4 |
A |
$0.00 |
$0 |
D/D |
16,797 |
45,186 |
|
- |
|
Griffin John M. |
General Counsel |
|
2020-11-02 |
4 |
A |
$0.00 |
$0 |
D/D |
34,716 |
130,023 |
|
- |
|
Verstreken Jan |
Group President, International |
|
2020-10-26 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
25,981 |
|
3% |
|
Oberton Karleen Marie |
Chief Financial Officer |
|
2020-09-22 |
4 |
OE |
$26.21 |
$143,133 |
D/D |
5,461 |
34,417 |
|
- |
|
Oberton Karleen Marie |
Chief Financial Officer |
|
2020-09-21 |
4 |
AS |
$62.50 |
$937,500 |
D/D |
(15,000) |
28,956 |
|
26% |
|
Oberton Karleen Marie |
Chief Financial Officer |
|
2020-09-21 |
4 |
OE |
$26.21 |
$393,150 |
D/D |
15,000 |
43,956 |
|
- |
|
Daugherty Sean S. |
Group President, BSH & Surg.Of |
|
2020-08-31 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
14,507 |
|
30% |
|
Cohn Benjamin Jordan |
Principal Accounting Officer |
|
2020-08-03 |
4 |
S |
$71.22 |
$350,810 |
D/D |
(4,924) |
16,713 |
|
-4% |
|
Cohn Benjamin Jordan |
Principal Accounting Officer |
|
2020-08-03 |
4 |
OE |
$23.82 |
$71,127 |
D/D |
2,986 |
19,699 |
|
- |
|
Valenti Peter J. Iii |
Division Pres., Breast Health |
|
2020-06-30 |
4 |
AS |
$54.07 |
$567,357 |
D/D |
(10,493) |
59,991 |
|
17% |
|
Valenti Peter J. Iii |
Division Pres., Breast Health |
|
2020-06-30 |
4 |
OE |
$26.21 |
$275,022 |
D/D |
10,493 |
70,484 |
|
- |
|
Crawford Sally |
Director |
|
2020-05-22 |
4 |
S |
$51.99 |
$1,661,081 |
D/D |
(31,950) |
126,847 |
|
-29% |
|
Valenti Peter J. Iii |
Division Pres., Breast Health |
|
2020-05-22 |
4 |
S |
$51.82 |
$543,779 |
D/D |
(10,493) |
59,991 |
|
-29% |
|
Valenti Peter J. Iii |
Division Pres., Breast Health |
|
2020-05-22 |
4 |
OE |
$26.21 |
$275,022 |
D/D |
10,493 |
70,484 |
|
- |
|
Thornal Kevin R |
Div. President, Diagnostics |
|
2020-05-15 |
4 |
S |
$51.51 |
$715,426 |
D/D |
(13,888) |
17,026 |
|
-25% |
|
Thornal Kevin R |
Div. President, Diagnostics |
|
2020-05-15 |
4 |
OE |
$26.01 |
$361,227 |
D/D |
13,888 |
30,914 |
|
- |
|
Macmillan Stephen P |
Chairman, President and CEO |
|
2020-05-13 |
4 |
S |
$50.97 |
$9,735,257 |
D/D |
(190,996) |
1,722,442 |
|
-24% |
|
Macmillan Stephen P |
Chairman, President and CEO |
|
2020-05-13 |
4 |
OE |
$22.29 |
$4,814,551 |
D/D |
215,996 |
1,913,438 |
|
- |
|
Garrett Scott T |
Director |
|
2020-05-01 |
4 |
OE |
$20.34 |
$492,309 |
D/D |
24,204 |
51,385 |
|
- |
|
Griffin John M. |
General Counsel |
|
2020-04-28 |
4 |
AS |
$50.00 |
$245,300 |
D/D |
(4,906) |
95,307 |
|
16% |
|
Griffin John M. |
General Counsel |
|
2020-04-28 |
4 |
OE |
$32.38 |
$158,856 |
D/D |
4,906 |
97,440 |
|
- |
|
Crawford Sally |
Director |
|
2020-03-09 |
4 |
AS |
$43.57 |
$491,317 |
D/D |
(11,146) |
158,797 |
|
31% |
|
1696 Records found
|
|
Page 11 of 68 |
|
|